Histology
Benign Squamous Cell Neoplasm
CI-CAN-00000548Explore in graph →
Non-malignant27 active trials
- NCIt
- C4742
Loading cancer entity…
Histology
CI-CAN-00000548Explore in graph →
Clinical trials
102 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05919264 | FOG-001 in Locally Advanced or Metastatic Solid Tumors | recruiting | Phase 1 / Phase 2 | 619 | Parabilis Medicines, Inc.INDUSTRY | 2 | Aug 17, 2026 | clinicaltrials |
| NCT06970145 | Safety and Efficacy of Anlotinib in the Treatment of Recurrent Craniopharyngioma | recruiting | Phase 1 / Phase 2 | 57 | Nanfang Hospital, Southern Medical UniversityOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT05688488 |
| Clinical Study of Curcumin in Preventing Postoperative Adhesion of Bilateral Vocal Cords |
| recruiting |
| Phase 1 / Phase 2 |
| 100 |
| Eye & ENT Hospital of Fudan UniversityOTHER |
| 1 |
| May 6, 2023 |
| clinicaltrials |
Data updated 22 days agoSource updated Aug 17, 2026source: clinicaltrials